Related Experiment Video
Updated: May 15, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Renal vasculitis in 2012: reclassification and the introduction of biologicals
1Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. c.g.m.kallenberg@umcg.nl
Abstract:
2012 saw the classification of the systemic vasculitides revised. Genetic studies showed that granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are different diseases with aberrant immune responses to different autoantigens. B-cell depletion with rituximab also acquired a primary role in the treatment of GPA and MPA, as well as in cryoglobulinaemic vasculitis.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Cardiovascular Drugs: Classification based on Therapeutic Indications
Nephrotic Syndrome II : Assessment and Medical Management
Drug Products: Biologics, Biosimilars and Interchangeables
Therapeutic Drug Monitoring: Overview and Classification
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

